Imaging Mass Spectrometry of Intact Biomolecules in Tissue Sections - Proteomic and Metabolomic Approaches to Biomarker Discovery - page 395

56. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel
second messenger

chemistry in drug development. Bioanalysis 2011; (21):

3

in cellular signal transduction. 2427 e 41.

69. Takai N, Tanaka Y, Inazawa K, Saji H. Quantitative
analysis of pharmaceutical drug distribution in
multiple organs by imaging mass spectrometry. Rapid
Commun Mass Spectrom 2012;

(5992):315 e 21.
57. Khan WA, Blobe GC, Hannun YA. Arachidonic acid
and free fatty acids as second messengers and the role
of protein kinase C. Cell Signal 1995;

Nature 1984;

312

(3):171 e 84.
58. Liu Y, Chen Y, Momin A, et al. Elevation of sulfatides
in ovarian cancer: an integrated transcriptomic and
lipidomic analysis including tissue-imaging mass
spectrometry. Mol Cancer 2010;

(13):1549 e 56.
70. Goodwin RJ, Nilsson A, Borg D, et al. Conductive
carbon tape used for support and mounting of both
whole animal and fragile heat-treated tissue sections for
MALDI MS imaging and quantitation.

7 26

:186 e 99.
59. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E,
Degani H. Metabolic markers of breast cancer: enhanced
choline metabolism and

J Proteomics

9

:4912 e 20.
71. Chacon A, Zagol-Ikapitte I, Amarnath V, et al. On-tissue
chemical derivatization of 3-methoxysalicylamine for
MALDI-imaging mass spectrometry. J Mass Spectrom
2011;

2012;

75

reduced choline-ether-

(7):1966 e 70.
60. Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM.
Novel role for apolipoprotein E in the central nervous
system. Modulation of sulfatide content. J Biol Chem
2003;

phospholipid synthesis. Cancer Res 2002;

62

(8):840 e 6.
72. Trim PJ, Henson CM, Avery JL, et al. Matrix-assisted
laser desorption/ionization-ion mobility separation-
mass spectrometry imaging of vinblastine in whole
body tissue sections. Anal Chem 2008;

46

(10):8043 e 51.
61. Woods AS, Jackson SN. Brain tissue lipidomics:
direct probing using matrix-assisted laser desorption/
ionization mass spectrometry. AAPS J 2006;

278

(22):8628 e 34.
73. Goodwin RJ, Mackay CL, Nilsson A, et al. Qualitative
and quantitative MALDI imaging of the positron
emission tomography ligands raclopride (a D2 dopa-
mine antagonist) and SCH 23390 (a D1 dopamine
antagonist) in rat brain tissue sections using a solvent-
free dry matrix application method. Anal Chem 2011;
83

80

8 (2):E391 e 5.

62. Jackson SN, Wang HY, Woods AS. In situ structural

characterization of phosphatidylcholines in brain tissue
using MALDI-MS/MS. J Am Soc Mass Spectrom 2005;
16

(12):2052 e 6.
63. Angel PM, Spraggins JM, Baldwin HS, Caprioli R.
Enhanced sensitivity for high spatial resolution lipid
analysis by negative ion mode matrix assisted laser
desorption ionization imaging mass spectrometry. Anal
Chem 2012;

(24):9694 e 701.
74. Crecelius AC, Cornett DS, Caprioli RM, Williams B,
Dawant BM, Bodenheimer B. Three-dimensional visu-
alization of protein expression in mouse brain struc-
tures using imaging mass spectrometry. J Am Soc Mass
Spectrom 2005;

(3):1557 e 64.
64. Menger RF, Stutts WL, Anbukumar DS, Bowden JA,
Ford DA, Yost RA. MALDI mass spectrometric
imaging of cardiac tissue following myocardial infarc-
tion in a rat coronary artery ligation model. Anal Chem
2012;

84

(7):1093 e 9.
75. Andersson M, Groseclose MR, Deutch AY,
Caprioli RM. Imaging mass spectrometry of proteins
and peptides: 3D volume reconstruction. Nature Met
2008;

16

(2):1117 e 25.
65. Starkopf J, Andreasen TV, Bugge E, Ytrehus K. Lipid
peroxidation, arachidonic acid and products of the
lipoxygenase pathway in ischaemic preconditioning of
rat heart. Cardiovasc Res 1998;

(1):101 e 8.
76. Sinha TK, Khatib-Shahidi S, Yankeelov TE, et al. Inte-
grating spatially resolved three-dimensional MALDI
IMS with in vivo magnetic resonance imaging. Nature
Met 2008;

84 5

(1):66 e 75.
66. Reyzer ML, Caprioli RM. MALDI-MS-based imaging of
small molecules and proteins in tissues. Curr Opin Chem
Biol 2007;

(1):57 e 9.
77. Attia AS, Schroeder KA, Seeley EH, et al. Monitoring
the in

37 5

ammatory response to infection through the
integration of MALDI IMS and MRI. Cell Host Microbe
2012;

(1):29 e 35.
67. Stoeckli M, Staab D, Schweitzer A. Compound and
metabolite distribution measured by MALDI mass
spectrometric imaging in whole-body tissue sections.
Int J Mass Spectrom 2007;

11

(6):664 e 73.
78. Spraggins JM, Caprioli RM. High-speed MALDI-TOF
imaging mass spectrometry: rapid ion image
acquisition and considerations for next generation
instrumentation. J Am Soc Mass Spectrom 2011;

11

(2-3):195 e 202.
68. Castellino S, Groseclose MR, Wagner D. MALDI
imaging mass spectrometry: bridging biology and

260

22 (6):

1022 e 31.